Role of coronary angiography in patients with a non-diagnostic electrocardiogram following out of hospital cardiac arrest: Rationale and design of the multicentre randomized controlled COUPE trial.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 27 6 2019
medline: 17 6 2021
entrez: 26 6 2019
Statut: ppublish

Résumé

Coronary artery disease (CAD) is a major cause of out-of-hospital cardiac arrest (OHCA). The role of emergency coronary angiography (CAG) and percutaneous coronary intervention (PCI) following cardiac arrest in patients without ST-segment elevation myocardial infarction (STEMI) remains unclear. We aim to assess whether emergency CAG and PCI, when indicated, will improve survival with good neurological outcome in post-OHCA patients without STEMI who remain comatose. COUPE is a prospective, multicentre and randomized controlled clinical trial. A total of 166 survivors of OHCA without STEMI will be included. Potentially non-cardiac aetiology of the cardiac arrest will be ruled out prior to randomization. Randomization will be 1:1 for emergency (within 2 h) or deferred (performed before discharge) CAG. Both groups will receive routine care in the intensive cardiac care unit, including therapeutic hypothermia. The primary efficacy endpoint is a composite of in-hospital survival free of severe dependence, which will be evaluated using the Cerebral Performance Category Scale. The safety endpoint will be a composite of major adverse cardiac events including death, reinfarction, bleeding and ventricular arrhythmias. This study will assess the efficacy of an emergency CAG versus a deferred one in OHCA patients without STEMI in terms of survival and neurological impairment.

Sections du résumé

BACKGROUND BACKGROUND
Coronary artery disease (CAD) is a major cause of out-of-hospital cardiac arrest (OHCA). The role of emergency coronary angiography (CAG) and percutaneous coronary intervention (PCI) following cardiac arrest in patients without ST-segment elevation myocardial infarction (STEMI) remains unclear.
AIMS OBJECTIVE
We aim to assess whether emergency CAG and PCI, when indicated, will improve survival with good neurological outcome in post-OHCA patients without STEMI who remain comatose.
METHODS METHODS
COUPE is a prospective, multicentre and randomized controlled clinical trial. A total of 166 survivors of OHCA without STEMI will be included. Potentially non-cardiac aetiology of the cardiac arrest will be ruled out prior to randomization. Randomization will be 1:1 for emergency (within 2 h) or deferred (performed before discharge) CAG. Both groups will receive routine care in the intensive cardiac care unit, including therapeutic hypothermia. The primary efficacy endpoint is a composite of in-hospital survival free of severe dependence, which will be evaluated using the Cerebral Performance Category Scale. The safety endpoint will be a composite of major adverse cardiac events including death, reinfarction, bleeding and ventricular arrhythmias.
CONCLUSIONS CONCLUSIONS
This study will assess the efficacy of an emergency CAG versus a deferred one in OHCA patients without STEMI in terms of survival and neurological impairment.

Identifiants

pubmed: 31237435
doi: 10.1177/2048872618813843
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

S131-S137

Auteurs

Ana Viana-Tejedor (A)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Albert Ariza-Solé (A)

Cardiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.

Manuel Martínez-Sellés (M)

Cardiology Department, Hospital General Universitario Gregorio Marañón, CIBERCV, Universidad Complutense, Universidad Europea, Madrid, Spain.

Manuel Jiménez Mena (MJ)

Cardiology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Montserrat Vila (M)

Cardiology Department, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Cosme García (C)

Cardiology Department, Hospital Universitari Germans Trias i Pujol, CIBERCV, Barcelona, Spain.

J M García Acuña (JM)

Cardiology Department, Hospital Universitario de Santiago de Compostela, CIBERCV, Spain.

Jordi Bañeras (J)

Cardiology Department, Hospital Universitario Vall d'Hebron, CIBERCV, Barcelona, Spain.

Juan C García Rubira (JC)

Cardiology Department, Hospital Virgen de la Macarena, Seville, Spain.

Pablo J Pérez (PJ)

Cardiology Department, Hospital Universitario de Canarias, Tenerife, Spain.

Carlos T Querol (CT)

Cardiology Department, Hospital Universitari Arnau de Vilanova, Lleida - IRBLL, Lleida, Spain.

Gemma Pastor (G)

Cardiology Department, Hospital Clínico Universitario de Valladolid, CIBERCV, Valladolid, Spain.

Rut Andrea (R)

Instituto Cardiovascular, Hospital Clinic, IDIBAPS, Universidad de Barcelona, Institut de Investigacions Mèdiques Pi i Sunyer, Spain.

Pablo L Osorio (PL)

Cardiology Department, Institut d Investigación Biomedica Dr. Josep Trueta de Girona, CIBERCV, Girona, Spain.

Norberto Alonso (N)

Cardiology Department, Hospital Universitario de León, Spain.

Cristina Martínez (C)

Intensive Care Medicine Department, Hospital Universitario Príncipe de Asturias, Madrid, Spain.

María Pérez Rodríguez (M)

Cardiology Department. Hospital Universitari de Tarragona Joan XXIII. Tarragona, Spain.

Francisco J Noriega (FJ)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Carlos Ferrera (C)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Pablo Salinas (P)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Iván Núñez Gil (IN)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Antonio Fernández Ortiz (AF)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Carlos Macaya (C)

Cardiology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH